Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05452031 · ClinicalTrials.gov registry record · NA
A Dyadic Sleep Health Approach for Persons With Alzheimer's Disease and Caregivers
A NA study of Sleep, sponsored by University of California, Los Angeles.
- Recruiting
- Registry status
- NA
- Development phase
- 672
- Enrollment target
- 3
- Study locations
NCT05452031: Recruiting NA study of Sleep, sponsored by University of California, Los Angeles.
NCT05452031 is a NA study of Sleep that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 672 participants, below the 4,162-participant average among 151 other Sleep trials with a reported enrollment target (84% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05452031, a NA study of Sleep, is actively recruiting participants, sponsored by University of California, Los Angeles.
- RECRUITING
- Registry status
- NA
- Development phase
- 672 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is a randomized controlled trial over 5 years, using Stage II of the NIH-defined stage model for behavioral intervention development. We will evaluate the efficacy of the sleep intervention program (Care2Sleep) on sleep, health status measures, and quality of life (for dyads), and inflammation (for caregivers only). Eligible participants will be randomly assigned to in-person Care2Sleep, telehealth Care2Sleep, or to an in-person education control group. The Care2Sleep programs and the control education program will consist of five sessions. The intervention and control programs will begin after baseline assessment and randomization. Posttreatment assessments will be performed immediately after the last session and at 6-month follow-up.
Primary Outcome
Nighttime sleep efficiency (i.e., mean percent of time in bed spent asleep) will be calculated from 7 days of wrist actigraphy for patients and caregivers. Range from 0 to 100% with a higher percent indicating better objective sleep quality
Conditions Studied
Interventions
- BEHAVIORAL Sleep Education
- BEHAVIORAL Care2Sleep
Study Locations (3)
California
- University of California San Diego - La Jolla
- University of California Los Angeles - Los Angeles
- Veterans Affairs Greater Los Angeles Healthcare System - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 672 participants |
| Start Date | 2022-11-09 |
| Est. Completion | 2027-08-31 |
| Phase | NA |
What NCT05452031 shows while recruiting
NCT05452031 is an interventional study that assigns participants to a tested intervention. The registered 672 participants enrollment target is mid-sized for trials with a published cap, below the 4,162-participant average among 151 other Sleep trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Sleep appearing as the primary indexed condition, and to 2 interventions - of which Sleep Education is the first listed.
NCT05452031 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05452031 about?
NCT05452031 is a clinical study titled "A Dyadic Sleep Health Approach for Persons With Alzheimer's Disease and Caregivers". This is a randomized controlled trial over 5 years, using Stage II of the NIH-defined stage model for behavioral intervention development. We will evaluate the efficacy of the sleep intervention program (Care2Sleep) on sleep, health status measures, and quality of life (for dyads), and inflammation ...
What is the current status of trial NCT05452031?
This trial is currently recruiting. It is a NA study. The enrollment target is 672 participants. The study started on 2022-11-09. Estimated completion is 2027-08-31.
What conditions does trial NCT05452031 study?
This clinical trial studies the following conditions: Sleep.
What interventions are being tested in trial NCT05452031?
The interventions under investigation include: Sleep Education (BEHAVIORAL), Care2Sleep (BEHAVIORAL).
Who is sponsoring clinical trial NCT05452031?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05452031 being conducted?
This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05452031's enrollment target sits among peer trials
672 10th of 151 higher than 142 of 151 other Sleep trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sleep trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Student Exercise and Sleep Timing Study - Part 2
RECRUITING · NA
-
The Effects of Sleep on Human Microbiota: Implications for Health and Disease
RECRUITING · NA
-
The Goodnight Screen Media Study
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
Shifting Sleep Timing in Teens
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05493254 · 672 participants · NA
Enhancing Smoking Cessation Via Telehealth Options in Primary Care
- NCT06651086 · 672 participants · NA
Hybrid Effectiveness-Implementation Trial of an Executive Functioning Intervention for Children's Mental Health Services
- NCT07184944 · 671 participants · Phase 3
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- NCT07185009 · 671 participants · Phase 3
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI